Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.

MLA

Giralt, S., et al. “Engraftment of Allogeneic Hematopoietic Progenitor Cells with Purine Analog-Containing Chemotherapy: Harnessing Graft-versus-Leukemia without Myeloablative Therapy.” Blood, vol. 89, no. 12, June 1997, pp. 4531–36. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9192777&authtype=sso&custid=ns315887.

APA

Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondón, G., Anderlini, P., O’Brien, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Kørbling, M., Keating, M., Kantarjian, H., & Champlin, R. (1997). Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood, 89(12), 4531–4536.

Chicago

Giralt, S, E Estey, M Albitar, K van Besien, G Rondón, P Anderlini, S O’Brien, et al. 1997. “Engraftment of Allogeneic Hematopoietic Progenitor Cells with Purine Analog-Containing Chemotherapy: Harnessing Graft-versus-Leukemia without Myeloablative Therapy.” Blood 89 (12): 4531–36. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9192777&authtype=sso&custid=ns315887.